linezolidtigecyclineechinocandinsdaptomycinaztreonammeropenemertapenemvancomycincarbapenemslast-generation cephalosporins+6 more
… were reviewed, mainly meropenem (39.7%), ertapenem (21.2%) and linezolid (6.2%). Most treatments were empirical (52.4%) or targeted (42.…